Dr. Sofya Ilmer, General Practice Medicare: Not Enrolled in Medicare Practice Location: 72d Medical Group, 7050 Air Depot Blvd, Blvd 1094, Tinker Afb, OK 73145 Phone: 405-582-6610 |
Marco Antonio Grieco, DO General Practice Medicare: Not Enrolled in Medicare Practice Location: 7050 Air Depot Blvd Bldg 1094, Tinker Afb, OK 73145 Phone: 405-734-2778 Fax: 405-736-3892 |
Dr. Sally Charles Hamm, MD General Practice Medicare: Medicare Enrolled Practice Location: 7050 Air Depot Blvd Bldg 1094, Tinker Afb, OK 73145 Phone: 702-582-6052 |
Dr. Mackenzie Rebecca Berry, DO General Practice Medicare: Not Enrolled in Medicare Practice Location: 7050 Air Depot Blvd Ste 1094, Tinker Afb, OK 73145 Phone: 405-734-2778 |
News Archive
The Gladstone Institutes announces the creation of Cure Network Ventures Inc. and Cure Network Dolby Acceleration Partners, LLC, a business endeavor with Dolby Family Ventures and Evotec AG, which will focus on Alzheimer's disease. Working through Cure Network Ventures, Inc., the new company will help expedite the translation of relevant scientific discoveries from the Gladstone Institute of Neurological Disease into the development of potential therapies.
Elevated blood levels of high-density lipoprotein or "good" cholesterol, typically thought to protect against heart disease, may do the opposite in women with type 1 diabetes, according to a University of Pittsburgh Graduate School of Public Health study being presented at the 70th Scientific Sessions of the American Diabetes Association.
On average, Americans die sooner and experience higher rates of disease and injury than people in other high-income countries, says a new report from the National Research Council and Institute of Medicine. The report finds that this health disadvantage exists at all ages from birth to age 75 and that even advantaged Americans - those who have health insurance, college educations, higher incomes, and healthy behaviors - appear to be sicker than their peers in other rich nations.
Oxygen Biotherapeutics, Inc., announced today that it has entered into a License and Supply Agreement with the Cosmetics Division of Valor SA of Lausanne, Switzerland, for Dermacyte, a perfluorocarbon based cosmetic product currently manufactured and distributed by Oxygen Biotherapeutics.
› Verified 6 days ago